Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
22nd Century Group Inc. develops and commercializes reduced-nicotine tobacco products built on proprietary plant biotechnology. Its VLN® combustible cigarette products use low-nicotine tobacco and are described in company materials as FDA-authorized reduced nicotine cigarettes in the United States. Company updates commonly address VLN retail distribution, state authorizations, PMTA-related product expansion, licensing strategy, tobacco-variety research and engagement with FDA and public-health stakeholders.
News also covers operating results for the tobacco business, including branded VLN products, contract manufacturing volumes, filtered cigars and other distributed tobacco products. Recent company reporting frames results around commercial expansion, cost management, higher-margin branded products and the completed exit from the hemp/cannabis business.
22nd Century Group, Inc. (Nasdaq: XXII) has announced findings from a recent study demonstrating that its reduced nicotine content (RNC) cigarettes significantly aid in smoking cessation and lower toxicant exposure without negatively affecting mental health. The study involved adult smokers with mood or anxiety disorders, showing reduced nicotine dependence and cigarette consumption among those using RNC cigarettes. CEO James A. Mish emphasized the positive public health implications of reduced nicotine policies and their potential to save millions of lives.
22nd Century Group (Nasdaq: XXII) will release its third quarter 2022 financial results on November 8, 2022, at 6:00 a.m. ET. A conference call will follow at 10:00 a.m. ET, featuring CEO James A. Mish, President John Miller, and CFO Hugh Kinsman. They will discuss company updates and the financial results. Investors can participate in a Q&A session through a webcast. The live event will be available on 22nd Century's Investor Relations website, along with an archived replay.
22nd Century Group, Inc. (XXII) announces the expansion of its VLN® reduced nicotine cigarettes into Utah, Arizona, and New Mexico, following the Colorado launch. The company aims to tap into a massive market, emphasizing that every 1% of the U.S. market correlates to approximately $800 million in retail sales. With favorable MRTP excise tax programs in these states, 22nd Century plans to utilize established partners for efficient distribution. VLN® products are designed to help adult smokers reduce their nicotine intake, with previous pilot programs demonstrating success in consumer recommendations.
22nd Century Group, Inc. (Nasdaq: XXII) has announced that CEO James A. Mish will present at the LD Micro Main Event Investor Conference in Los Angeles on October 26, 2022, at 11:00 a.m. PT. The event is highly anticipated, with limited space for investor meetings due to demand. Institutional investors can arrange meetings through LD Micro representatives or by contacting the investor relations team. A live and archived webcast of the presentation will be available on the company's Investor Relations website shortly after the event.
22nd Century Group (Nasdaq: XXII) announced that CEO James A. Mish will present at the 7th Annual Dawson James Small Cap Growth Conference on October 12, 2022, in Jupiter, Florida. The company's presentation is scheduled for 10:30 AM ET. Interested institutional investors can request meetings with management through their representatives or by contacting the investor relations team at investorrelations@xxiicentury.com. 22nd Century Group specializes in agricultural biotechnology, focusing on reduced nicotine tobacco, hemp, and cannabis technologies.
22nd Century Group has launched VLN® cigarettes in Colorado, the first FDA-approved Modified Risk Tobacco Product, featuring 95% less nicotine than regular cigarettes. This initiative aims to help smokers reduce consumption and quit smoking. VLN® King and Menthol King are now available at Smoker Friendly locations and will soon be in Circle K stores. Clinical trials show switching to VLN® can reduce cigarettes per day by 50% after 20 weeks. The rollout aligns with public health goals and aims to reduce smoking-related deaths, particularly among Colorado's adult smokers.
22nd Century Group (XXII) has partnered with Creager Mercantile to enhance the distribution of its VLN® reduced nicotine content cigarettes across Colorado. This collaboration aims to boost availability in over 1,000 retail locations, including specialty shops and gas stations. VLN® cigarettes contain about 95% less nicotine than standard cigarettes, promoting a non-addictive alternative. The effort follows a successful pilot program in Chicago, establishing a channel for wider retail presence. This partnership represents a strategic move to tap into Colorado's retail market, with plans for further expansion nationwide.
22nd Century Group (Nasdaq: XXII) announced a partnership with Eagle Rock Distributing to launch its VLN® reduced nicotine cigarettes across Colorado starting September 2022. This collaboration aims to distribute VLN® to thousands of locations, including regional and national chains and independent retailers. VLN® cigarettes contain approximately 95% less nicotine, addressing health concerns associated with conventional smoking. The partnership follows a successful pilot program in Chicago, which showed high customer recommendation rates for VLN®. This initiative is aligned with the FDA's proposed nicotine cap to reduce smoking.
22nd Century Group (Nasdaq: XXII) aligns with the FDA and the Biden Administration's initiative to reduce nicotine content in cigarettes, aiming to help smokers cut down. Their VLN® reduced nicotine content cigarettes are designed to aid smokers in reducing their nicotine intake, with plans for expanded sales in Chicago following successful pilot results. The FDA's proposed actions could significantly impact public health, potentially helping over 5 million people quit smoking. These initiatives address the high addiction rates linked to nicotine and the associated health risks, including cancer.
22nd Century Group, Inc. (Nasdaq: XXII) announced the appointment of Lucie S. Salhany to its Board of Directors on September 12, 2022. Salhany, a renowned media executive with a history of successful product launches, will enhance the company's focus on tobacco harm reduction and its hemp/cannabis initiatives. Her experience includes being the first woman chair of a major broadcast network, and she will serve on the Corporate Governance and Finance committees. Board Chair Nora B. Sullivan and CEO James A. Mish expressed confidence in her ability to elevate the company's market profile.